Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease.
about
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel DiseaseEvidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in JapanGenetics of inflammatory bowel disease: the role of the HLA complexExtraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.Contribution of genetics to a new vision in the understanding of inflammatory bowel disease.Extraintestinal manifestations and complications in inflammatory bowel diseases.Recent advances in inflammatory bowel disease.Review article: the genetics of inflammatory bowel disease.IBD1 and IBD3 determine location of Crohn's disease in the Spanish population.Inflammatory bowel disease and spondylarthropathy.Clinical aspects and pathophysiology of inflammatory bowel disease.The genetic jigsaw of inflammatory bowel diseaseHLA-B27: natural function and pathogenic role in spondyloarthritis.DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.Unravelling the complex genetics of inflammatory bowel diseaseClinical implications of inflammatory bowel disease genetics on phenotype.Current status of genetics research in inflammatory bowel disease.Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.Genetics of inflammatory bowel disease: current status and future directions.Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine.Enteropathic spondyloarthritis: from diagnosis to treatment.How does genotype influence disease phenotype in inflammatory bowel disease?Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel DiseaseClinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease.Rheumatic manifestations of inflammatory bowel disease.Immunogenetics of drug-induced skin blistering disorders. Part II: synthesis.Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease?The future of molecular approaches to inflammatory bowel disease.Extraintestinal manifestations and complications in IBD.Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease.Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.Occult spondyloarthritis in inflammatory bowel disease.Relationship between articular and nonarticular manifestations in inflammatory bowel diseases.Role of HLA typing on Crohn's disease pathogenesis.Management of arthritis in patients with inflammatory bowel diseaseRheumatological manifestations in inflammatory bowel disease.Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease.Clinical and molecular characteristics of isolated colonic Crohn's disease.Inflammatory bowel disease: one or two diseases?
P2860
Q22241416-341CB873-3A61-4155-948D-B88C4BEE85A9Q26829392-C8CB62F5-21F5-4E1B-94BA-0610A1EA5682Q28245979-9439A743-5390-4C9B-947C-EBF2F4EDA534Q33532262-02046CF3-377A-414D-A3ED-8309FCC28E45Q33866970-B7BBA1DC-8FDF-40FB-8C45-094FCF6F2431Q33866998-02F885B3-4C2A-4659-B748-74F9907EB291Q34188405-9890B0E0-14A7-46C4-884E-225655068A57Q34266210-323438B0-42A5-4D4C-914A-C3AE1B4B4977Q34380726-127A7983-0869-45EC-B198-791746E94B16Q34474693-1431B992-02AA-4CF2-935D-362A9BFAD645Q34487217-ED596B7A-40CE-4EA8-9467-652801DA5322Q34600985-C51C1396-1332-4818-8E36-5698E14E414FQ34731174-4902EE0F-2189-4EE2-B3F1-C2A3FCB8673AQ35597788-B200D29D-7A67-49AE-A07C-941762A2A663Q35813384-05C2686A-DEBE-459F-8704-1DE8403DA207Q36021426-23F28977-3274-4BD2-B26F-CA694AC60C9DQ36233839-1D6383FB-6245-46A2-A7DC-3F4C1EA9D54DQ36446276-3BB157A5-D623-4B8C-9078-39BC16ED5D58Q36589391-694B6B3F-DA12-407C-AE9E-F720066D7583Q36635088-24734126-E5B6-481D-BA75-662B1715C89FQ36801108-832C15CA-4608-4817-A8AD-5CF9F2576687Q36830824-57610703-ABF1-42A2-AA47-B11FD7CEC921Q37038666-5458984A-01C4-40D8-B8C2-CB7A7A3F8661Q37098461-2C02722C-C546-43F3-9774-610A73DE15D9Q37203396-246B4788-3943-4283-B3EB-41E74B9B7DA7Q37445601-7DC1BE99-0ADC-4C13-8A95-ECFDC52074EBQ37486715-8A7E3D23-01DA-4E07-9F24-4F4A95FDFC35Q37495746-EE9C064D-CC0C-4276-9AE3-A8736BBC9354Q37587990-4681254B-3EF0-4674-8EF0-AABEEBA5F3A2Q38120146-F3B96C71-B35A-4EA3-8030-A64C37849714Q38260150-276B896F-F365-41B7-BBD6-062AF3072B87Q38561218-3B9144FB-E374-43E1-A2BE-EFFE471ED5CAQ38583788-1C61A2E2-1656-4484-9842-DFB2DE975FB8Q40447808-A85454F1-184E-4D0C-8E9E-2E290AD5D23DQ42093953-3FB38E04-79E9-4BF1-BC39-C5A71A4D5533Q42285921-2D6FCAD0-CFFF-4078-9058-15CDC33DFA5CQ42406810-9760AEBB-C173-4E3F-919B-F537DE7C64D8Q43713135-7809F4DA-ED12-4F7E-9B2A-A3FA8D869A72Q44743510-872452A1-4E2B-4A12-A935-860B79F44C2CQ44745139-8D25D785-D83B-4D12-A91D-895492F200CC
P2860
Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Clinical phenotype is related ...... of inflammatory bowel disease.
@ast
Clinical phenotype is related ...... of inflammatory bowel disease.
@en
type
label
Clinical phenotype is related ...... of inflammatory bowel disease.
@ast
Clinical phenotype is related ...... of inflammatory bowel disease.
@en
prefLabel
Clinical phenotype is related ...... of inflammatory bowel disease.
@ast
Clinical phenotype is related ...... of inflammatory bowel disease.
@en
P2093
P1433
P1476
Clinical phenotype is related ...... of inflammatory bowel disease.
@en
P2093
Hill Gaston JS
Orchard TR
Thiyagaraja S
Wordsworth BP
P304
P356
10.1016/S0016-5085(00)70209-5
P407
P577
2000-02-01T00:00:00Z